# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000010
Filing Date
2025-02-25
Accepted
2025-02-25 16:06:51
Documents
8
Period of Report
2025-02-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | a2025-02x25directorappoint.htm | 6-K | 22584
2 | EX-99.1 | exhibit991.htm | EX-99.1 | 9154
3 | EX-99.2 | exhibit992.htm | EX-99.2 | 4118
4 |  | exhibit991001.jpg | GRAPHIC | 271009
5 |  | exhibit991002.jpg | GRAPHIC | 272695
6 |  | exhibit992001.jpg | GRAPHIC | 104823
7 |  | exhibit992002.jpg | GRAPHIC | 106314
8 |  | exhibit992003.jpg | GRAPHIC | 36852
| Complete submission text file | 0001345099-25-000010.txt |  | 1127615

Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25663052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)